Novavax (UK) Price on July 26, 2024
0A3S Stock | 11.90 3.06 34.62% |
Below is the normalized historical share price chart for Novavax extending back to September 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novavax stands at 11.90, as last reported on the 1st of December, with the highest price reaching 11.90 and the lowest price hitting 9.81 during the day.
If you're considering investing in Novavax Stock, it is important to understand the factors that can impact its price. Novavax appears to be risky, given 3 months investment horizon. Novavax has Sharpe Ratio of 0.06, which conveys that the firm had a 0.06% return per unit of risk over the last 3 months. By analyzing Novavax's technical indicators, you can evaluate if the expected return of 0.77% is justified by implied risk. Please exercise Novavax's Downside Deviation of 14.79, mean deviation of 7.14, and Risk Adjusted Performance of 0.0552 to check out if our risk estimates are consistent with your expectations.
At this time, Novavax's Common Stock is comparatively stable compared to the past year. Sale Purchase Of Stock is likely to gain to about 1.4 B in 2024, whereas Other Stockholder Equity is likely to drop (7.7 M) in 2024. . Novavax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 8.5832 | 50 Day MA 7.9857 | Beta 2.088 |
Novavax |
Sharpe Ratio = 0.06
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 0A3S | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
12.77 actual daily | 96 96% of assets are less volatile |
Expected Return
0.77 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Novavax is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novavax by adding it to a well-diversified portfolio.
Book Value (3.29) | Enterprise Value 759.9 M | Shares Float 143.4 M | Earnings Share (17.51) | Revenue Per Share 6.186 |
Novavax Valuation on July 26, 2024
It is possible to determine the worth of Novavax on a given historical date. On July 26, 2024 Novavax was worth 16.95 at the beginning of the trading date compared to the closed value of 16.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novavax stock. Still, in general, we apply an absolute valuation method to find Novavax's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novavax where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novavax's related companies.
Open | High | Low | Close | Volume | |
15.39 | 17.45 | 14.92 | 16.33 | 423,929 | |
07/26/2024 | 16.95 | 17.81 | 16.82 | 16.86 | 216,936 |
17.42 | 17.49 | 15.90 | 16.11 | 158,621 |
Backtest Novavax | | | Novavax History | | | Novavax Valuation | Previous | Next |
Novavax Trading Date Momentum on July 26, 2024
On July 29 2024 Novavax was traded for 16.11 at the closing time. The highest price during the trading period was 17.49 and the lowest recorded bid was listed for 15.90 . The volume for the day was 158.6 K. This history from July 29, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 4.45% . The trading delta at closing time to the current price is 32.68% . |
Novavax Fundamentals Correlations and Trends
By evaluating Novavax's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novavax's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novavax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novavax Stock history
Novavax investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novavax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novavax will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novavax stock prices may prove useful in developing a viable investing in Novavax
Last Reported | Projected for Next Year | ||
Net Loss | -592.1 M | -621.8 M |
Novavax Stock Technical Analysis
Novavax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Novavax Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Novavax cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Novavax December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Novavax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novavax shares will generate the highest return on investment. By undertsting and applying Novavax stock market strength indicators, traders can identify Novavax entry and exit signals to maximize returns
Novavax Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novavax's price direction in advance. Along with the technical and fundamental analysis of Novavax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novavax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0552 | |||
Jensen Alpha | 0.9562 | |||
Total Risk Alpha | (1.38) | |||
Sortino Ratio | 0.0425 | |||
Treynor Ratio | (0.48) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.